| 1 |
T-cell acute lymphoblastic leukemia
(1789 times)
|
Neoplasms
(697 times)
|
AML (121 times)
TCR (65 times)
MRD (63 times)
|
1979 Subset derivation of T-cell acute lymphoblastic leukemia in man.
|
| 2 |
T-cell ALL
(78 times)
|
Neoplasms
(38 times)
|
ALL (64 times)
B-ALL (19 times)
AML (7 times)
|
1984 Differential methylation of class I histocompatibility antigen genes in T-cell lines derived from two different types of T-cell malignancies.
|
| 3 |
T-cell acute lymphoblastic leukemia/lymphoma
(41 times)
|
Neoplasms
(8 times)
|
AML (2 times)
GSIs (2 times)
HSCs (2 times)
|
2000 Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.
|
| 4 |
T-cell leukemia
(25 times)
|
Neoplasms
(12 times)
|
AML (2 times)
11p13 ttc (1 time)
AICD (1 time)
|
1982 Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
|
| 5 |
T-lineage ALL
(11 times)
|
Neoplasms
(6 times)
|
ALL (8 times)
AML (3 times)
AKR1C3 (2 times)
|
1998 Detection of myeloperoxidase by flow cytometry in acute leukemia.
|
| 6 |
T-cell acute leukemia
(9 times)
|
Molecular Biology
(5 times)
|
ADC (1 time)
AML (1 time)
array-CGH (1 time)
|
1991 Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.
|
| 7 |
T-cell lineage ALL
(3 times)
|
Hematology
(3 times)
|
ALL (3 times)
B-lineage (1 time)
BCP (1 time)
|
2000 New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
|
| 8 |
T-cell acute leukemia/lymphoma
(2 times)
|
Neoplasms
(1 time)
|
---
|
2017 The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
|
| 9 |
T-cell acute lymphoblastic
(2 times)
|
Hematology
(2 times)
|
CNSL (2 times)
ALL (1 time)
B-ALL (1 time)
|
2002 Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
|
| 10 |
T-cell acute lymphoblastic lymphoma/leukemia
(2 times)
|
Neoplasms
(2 times)
|
DBC (1 time)
ERbeta (1 time)
I3C (1 time)
|
2013 The role of estrogen receptor beta in transplacental cancer prevention by indole-3-carbinol.
|
| 11 |
T-cell leukemia/lymphomas
(2 times)
|
Biochemistry
(1 time)
|
DeltaE (1 time)
EL (1 time)
ICN (1 time)
|
1997 Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.
|
| 12 |
T-cell lineage
(2 times)
|
Neoplasms
(1 time)
|
CDK (1 time)
DEX (1 time)
FACS (1 time)
|
2010 Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis.
|
| 13 |
translocations in acute T cell leukaemia's
(2 times)
|
Neoplasms
(2 times)
|
Inr (1 time)
TTG-2a (1 time)
|
1995 The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL).
|
| 14 |
type acute lymphocytic/lymphoblastic leukemia
(2 times)
|
Neoplasms
(1 time)
|
FBP (2 times)
FIRDeltaexon2 (2 times)
PB (2 times)
|
2015 Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
|
| 15 |
acute T-cell leukemia
(1 time)
|
Pathology
(1 time)
|
TCR (1 time)
Ti (1 time)
|
1989 A case of CD3+, CD4-, CD8-, WT31- acute T-cell leukemia.
|
| 16 |
characteristics ofT-acute lymphoblastic leukemia
(1 time)
|
Neoplasms
(1 time)
|
AgNORs (1 time)
DPP-IV (1 time)
|
1999 Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
|
| 17 |
precursor-T lymphoblastic leukemia
(1 time)
|
Hematology
(1 time)
|
LOH (1 time)
T-LBL (1 time)
|
2008 Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
|
| 18 |
T cell development and acute lymphoblastic leukemia
(1 time)
|
Biology
(1 time)
|
FACS (1 time)
|
2019 Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish.
|
| 19 |
T lymphoblastic lymphoma/leukaemia
(1 time)
|
Pathology
(1 time)
|
AML (1 time)
LMO2 (1 time)
|
2013 LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
|
| 20 |
T lymphocyte acute lymphoblastic leukemia
(1 time)
|
Immune System Diseases
(1 time)
|
---
|
2022 Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia.
|
| 21 |
T lymphocytic leukemia cells
(1 time)
|
Biochemistry
(1 time)
|
GLI1 (1 time)
Hh (1 time)
Smo (1 time)
|
2014 Inhibition of hedgehog signaling by GANT58 induces apoptosis and shows synergistic antitumor activity with AKT inhibitor in acute T cell leukemia cells.
|
| 22 |
T-cell acute lymphoblastic malignancies
(1 time)
|
Biochemistry
(1 time)
|
non-T-ALL (1 time)
SPG (1 time)
|
1988 Detection of GD3 ganglioside in childhood acute lymphoblastic leukemia with monoclonal antibody to GD3: restriction to immunophenotypically defined T-cell disease.
|
| 23 |
T-cell ALL/lymphoma
(1 time)
|
Neoplasms
(1 time)
|
ALL (1 time)
alpha7nAChR (1 time)
AML (1 time)
|
2019 Variation of nicotinic subtype alpha7 and muscarinic subtype M3 acetylcholine receptor expression in three main types of leukemia.
|
| 24 |
T-cell features
(1 time)
|
Neoplasms
(1 time)
|
ALL (1 time)
bcr (1 time)
TCR (1 time)
|
1990 Acute T-lymphocytic leukemia with Ph1 and 5q-chromosome abnormalities and rearrangements of bcr and TCR-delta genes.
|
| 25 |
T-cell immunophenotype of acute lymphoblastic leukemia
(1 time)
|
Hematology
(1 time)
|
HCT (1 time)
|
2015 How I treat T-cell acute lymphoblastic leukemia in adults.
|
| 26 |
T-cell leukemia ALL
(1 time)
|
Cell Biology
(1 time)
|
miRNAs (1 time)
|
2011 Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs.
|
| 27 |
T-cell lymphoblastic ALL
(1 time)
|
|
ALL (1 time)
B-ALL (1 time)
KAUH (1 time)
|
2021 Mutations Encountered in Acute Lymphoblastic Leukemia: A Retrospective Study in a Teaching Hospital in Jeddah, Saudi Arabia.
|
| 28 |
T-cell precursor acute lymphoblastic leukemia
(1 time)
|
Cell Biology
(1 time)
|
AML (1 time)
BCP-ALL (1 time)
MFI (1 time)
|
2005 Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
|
| 29 |
T-cell subtype of ALL
(1 time)
|
Allergy and Immunology
(1 time)
|
ALL (1 time)
VDAC (1 time)
|
2019 Mitochondria as emerging targets for therapies against Tcell acute lymphoblastic leukemia.
|
| 30 |
T-lymphoblastic leukaemic cells
(1 time)
|
Neoplasms
(1 time)
|
B-ALL (1 time)
HPLC (1 time)
|
1995 Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity.
|
| 31 |
T-lymphoblastic lymphoma with a picture of acute lymphoblastic leukemia
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1994 Histopathologic spectrum of AIDS-associated lesions in Maharaj Nakorn Chiang Mai Hospital.
|
| 32 |
T-lymphoblasts
(1 time)
|
Hematology
(1 time)
|
ANAE (1 time)
AP (1 time)
DAP IV (1 time)
|
1985 Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
|
| 33 |
TCRgammadelta+T-cell acute lymphoblastic leukemia
(1 time)
|
Neoplasms
(1 time)
|
CNV (1 time)
DFS (1 time)
|
2016 Risk stratification of T-cell Acute Lymphoblastic Leukemia patients based on gene expression, mutations and copy number variation.
|
| 34 |
therapeutic approaches, like T-lineage ALL
(1 time)
|
Hematology
(1 time)
|
ALL (1 time)
B-ALL (1 time)
MRD (1 time)
|
2004 Adult acute lymphoblastic leukaemia.
|
| 35 |
thymic ALL
(1 time)
|
Neoplasms
(1 time)
|
ALL (1 time)
|
1981 Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
|
| 36 |
translocation of human acute lymphoblastic leukemias
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1989 Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia.
|
| 37 |
treated for acute lymphatic T-cell leukemia
(1 time)
|
Medicine
(1 time)
|
CRMO (1 time)
CRP (1 time)
|
2009 Dangerous errors in the diagnosis and treatment of bony tuberculosis.
|
| 38 |
type ALL
(1 time)
|
Biology
(1 time)
|
ALL (1 time)
B-ALL (1 time)
cALL (1 time)
|
1991 Immunophenotyping of 515 cases of acute lymphoblastic leukemia in China.
|
A Search Service for Abbreviation / Long Form